Contract Research Organization

Our Contract Research Organization serves to aid industry with their development, execution, and management of early phase cellular immunotherapy trials. Thanks to our unique model, that has vertically integrated a Phase 1 Research Clinic with a high complexity CLIA Lab and a cGMP facility, all under one roof and at the point of care, we act as a one-stop service provider. We assist in refining your clinical development plan, developing technical documents. We provide direct custom BioSpecimen sourcing for your research use only clinical trials and offer guidance for regulatory submissions or oversight for a successful clinical trial management. BioCytics CRO offerings are here to support a long-range of research goals.

Early Phase CRO Services

CBOI’s Clinical Development Team offers end-to-end CRO services in the United States. Our team specializes in Immuno-Oncology and Cell & Gene therapies for early phase development for the treatment of solid malignancies and immune-mediated diseases. We offer a range of services, such as feasibility, initiation, execution, and completion, to help your site execute intricate clinical trials. Our medical and scientific team experts are here to help you.

Clinical Trials at CBOI

Clinical trials convey results of conceptual scientific research into better ways to prevent, diagnose, or treat cancer. Early phase clinical trial data have permitted significant advances within the field of immuno-oncology, enabling longevity and better quality of life for many cancer patients. Our staff is comprised of highly trained, experienced, and certified clinical research professionals well versed in managing the complexities of Phase I trial design and immune-related adverse event (irAE) management.​